FUNDC1 and Alzheimer disease: It provides a focused analysis of the specific functions and activation mechanisms of key receptors—including BNIP3, NIX, FUNDC1, and AMBRA1—in models of Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis.